Germany is one of the leading countries in diagnosis and treatment of endocrine diseases. Modern medical consultation and therapy methods not only affect the disease progress, but also help patients with diabetes mellitus to reduce the symptoms.
Here you find the information about services offered by certified Diabetes Centres in Germany.
Diabetes mellitus – urgent issue of our lifetime
According to statistical data 10 percent of Germans aged 20 to 79 have Type 1 or Type 2 diabetes. Nowadays 8 percent of the global population have diabetes. Treatment of diabetes mellitus is one of the main problems of modern medicine due to the large number of patients exposed to diabetes mellitus and numerous secondary diseases associated with it (cardiovascular disease, myocardial infarction, stroke, renal insufficiency, eye disease and limbs amputation risks).
Certified Diabetes Centres in Germany. Certification of German Diabetes Association (DDG).
The certification of Diabetes Centres in Germany is carried out in accordance with quality of standards of German Diabetes Association (DDG).
List of certified Diabetes Centres in Germany:
- Medical centres specialized in treatment for Type 2 diabetes
- Medical centres specialized in treatment for Type 1 diabetes
- Centres for diabetes treatment in children and teenagers
Types of Diabetes Centres:
- Out-patient clinics (health care facilities without ambulatory care)
- In-patient clinics (health care facilities with ambulatory care)
- Health care facilities as part of out-patient clinic/university hospital
- Ambulatory care clinics with the opportunity to stay only by day or at night
- Private clinic
List of services offered by German Diabetes Centres
Treatment for Type 2 diabetes:
- drug treatment
- conventional insulinotherapy
- intensive insulinotherapy (flexible insulin therapy)
- adaptation to insulin therapy
Treatment for Type 1 diabetes:
- intensive insulinotherapy (flexible insulin therapy)
- use of insulin pump
- adaptation to insulin therapy
- daily measurement of blood pressure (with Guardian REAL-Time System)
- gathering and elaborating of information with computer-assisted systems
Diabetes treatment during pregnancy:
- Medical consultation concerning nutrition, if necessary preparing to insulin therapy
- Treatment and care for pregnant women with Type 1 diabetes
- Treatment and care for pregnant women with Type 2 diabetes
- Close cooperation with specialists in gynaecology and midwifery
- Blood sugar control after birth
Treatment of secondary diseases associated with diabetes mellitus
- regular foot examination
- If necessary, the staff will treat the wound and help you to find appropriate shoes
- cooperation with skilled specialists like orthopaedists, surgeons and vascular surgeons
Affection of nerves of the lower limbs in diabetic patients
- regular peripheral nervous system examination of the lower extremities
- cooperation with neurologists
Renal affection in diabetic patients
- regular urinanalysis to indicate the amount of protein
- renal sonography (ultrasound of the kidney)
- cooperation with nephrologists
- drug treatment
- cooperation with andrologists
Affection of the visual system in diabetic patients
- regular examination of the eyeground by ophthalmologist
Affection of the cardiovascular system
- screening of coronary arteries with electrocardiography (ECG) and cardiac stress test
- echocardiography for examination of the heart function
- duplex ultrasonography to exam cerebral blood vessels and lower extremities
Surgical Treatment for Diabetes Mellitus
Surgical Treatment for Type I Diabetes
In the presence of certain strict indications (frequent and severe acute complications of diabetes, serious late complications, the ineffectiveness of conventional treatment) in Germany clinics resort to such high-technology surgical treatments for type I diabetes as isolated pancreas transplantation and simultaneous pancreas and kidney transplantation. These technically complex surgical interventions make it possible for patients to give up insulin injections, but they require a lifelong intake of drugs that suppress the immune system so as to prevent the rejection of transplanted organs.
Recently, thanks to the improvement of immunosuppression strategies, late fates of pancreas transplantations have improved. One of the promising policies of treatment to improve glucose control in patients with type I diabetes, in many cases leading to insulin independence, is pancreatic islet cell transplantation. This innovative high-technology treatment for type I diabetes is a safer alternative to pancreas transplantation. Islet cell transplantation has no major surgical risk and creates good prospects for glycemic control. For islet cell transplantation a minimally invasive percutaneous portal embolization technique is used: islets isolated from a donor pancreas are introduced into the liver via a catheter inserted into the portal vein.
The use of new techniques aimed at preventing the rejection of transplanted tissues makes it possible for the islets transplanted into the liver to function for quite a long time.
Surgical Treatment for Type II Diabetes
The age of patients diagnosed with type II diabetes, the most common form of this disease, is steadily decreasing. The main reasons for this are obesity and hypodynamia already in their younger years. Numerous studies in recent years have identified obesity as a key cause of type II diabetes. In 80% of patients with type II diabetes, the body weight exceeds the ideal one by 15% or more. Obesity is associated with insulin resistance. Insulin resistance can be caused by a decrease in the number of insulin receptors and their defects. The adipose tissue itself, with its endocrine function, secretes substances that affect the sensitivity of tissues to insulin.
German doctors consider achieving optimal body weight through lifestyle modification (a reduced energy value of food and regular exercise) to be the primary task in the treatment of patients with type II diabetes. Dietotherapy, which is the foundation of treatment for a significant proportion of patients, in combination with physical activity leads to a natural recovery of the normoglycemic state. If the blood glucose level cannot be controlled by these measures, hypoglycemic drugs are prescribed to ensure the compensation in diabetes and maintain an active lifestyle for many years.
The treatment protocols developed by German specialists include highly effective newest antidiabetic drugs, many of which have unique properties. Under certain conditions ‒ pregnancy, intercurrent diseases, surgeries, ineffectiveness of nutritional therapy and oral medications ‒ patients with type II diabetes need to use insulin either temporarily or permanently.
The desire to reduce the level of glycemia in patients with type II diabetes mellitus by using natural means, to minimize the use of drugs or completely eliminate them has led to the rapid development of the techniques of bariatric surgery ‒ weight loss surgery. Different types of gastrointestinal surgical procedures, originally developed for the treatment of obesity, often lead to the normalization of blood glucose levels, reduce or eliminate the need for drugs. The distinct positive effect of such operations served as the basis for the emergence of a new branch of medicine ‒ interventional diabetology.
At present experts of the International Diabetes Federation consider bariatric surgery as a complete method for the treatment of type II diabetes and recommend using it at earlier stages of the disease. In Germany, along with the classic bariatric operations performed, as a rule, by using a sparing laparoscopic technique, innovative minimally invasive techniques are also used. One of them is the TANTALUS system of gastric stimulation. The principle underlying it is the implantation of special stimulants that control the muscle activity of the stomach during meals. The system is already used by several hundred European patients. German doctors believe that innovations like the TANTALUS system can be an excellent alternative to traditional surgical techniques of treating diabetes.
Another promising technique is called the EndoBarrier Gastrointestinal Liner. During gastroscopy, a thin Teflon tube is inserted into the upper intestine, which creates a mechanical obstacle to food contact with the intestinal walls throughout the duodenum and partially the jejunum. This helps to reduce the absorption of substances and caloric value of eaten foods. German doctors consider the EndoBarrier therapy to be a sparing and very effective technique. In comparison with the existing surgical techniques of treatment, the EndoBarrier is not traumatic; the risk of postoperative complications is minimal. The technique helps to significantly reduce the content of glucose in the blood and decrease or completely eliminate the need for taking antidiabetic drugs in 80% of patients. The tube is removed a few months after the operation.
Clinics in Germany successfully practise one of the newest techniques for treating diabetes ‒ extracorporeal hemocorrection, a high-technology procedure based on modern bio- and nanotechnologies. Extracorporeal hemocorrection (gravitational blood surgery, efferent therapy) is a group of modern medical techniques based on the treatment of blood components (plasma, lymphocytes, platelets, erythrocytes, etc.) outside the patient’s body. The purpose of extracorporeal hemocorrection is to change the properties of blood components or to remove harmful substances that cause or maintain the disease. The main effects of extracorporeal hemocorrection are overcoming the development of drug resistance, the intensity of side effects by reducing the dose of the drug; improvement of blood flow, microcirculation in the tissues. Indications for the procedure of extracorporal hemocorrection in diabetic patients are unstable course of the disease; resistance to exogenous insulin; a high level of antibodies against pancreatic β-cells, anti-insulin antibodies, hyperlipidemia; increasing doses of drugs used; the development of complications of the disease. As a result of the procedure, it is possible to achieve an increase in sensitivity to glucose-lowering drugs, to reduce their dosage and glycemia level; to reduce the intensity of angiopathy, neuropathy, nephropathy; to prevent further progression of vascular and neurological complications.